在Cbl-b SH2域内结合并阻止基质结合的新型DEL击中优化
Jun Liang1, Michael J Lambrecht1, Teresita L Arenzana1
1Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
ACS medicinal chemistry letters
|June 19, 2024
概括
研究人员探索了小分子抑制剂,用于卡西塔斯B系淋巴瘤原基因-b (Cbl-b),这是T细胞激活的关键调节者. 他们发现了一种有前途的化合物,针对SH2域,推进Cbl-b抑制策略.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 卡西塔斯B系淋巴瘤原瘤基因-b (Cbl-b) 是一个RING E3连接酶,对T细胞激活调节至关重要.
- 抑制Cbl-b具有治疗潜力,但针对小分子的蛋白质-蛋白质相互作用是具有挑战性的.
研究的目的:
- 确定和开发Cbl-b的小分子抑制剂.
- 探索准Cbl-b的SH2域以阻止蛋白质-蛋白质相互作用的可行性.
主要方法:
- 对大型DNA编码库 (DEL) 对激活的Cbl-b进行选.
- 生物化学测试和表面等离子体共振 (SPR) 用于化合物验证.
- 晶学以确定抑制剂的结合方式.
主要成果:
- 从DEL屏幕上确定了一种Cbl-b抑制剂 (化合物1),其cis-同位素 (化合物2) 得到证实.
- 结晶结构显示,化合物2通过诱导适合方式与Cbl-b SH2域结合.
- 结构导向优化产生了具有可测量的,但高度的细胞活性的化合物27.
结论:
- 小分子可以通过准其SH2域来有效抑制Cbl-b.
- 这项工作为开发针对T细胞信号通路的新疗法提供了基础.
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Enzymes
81.4K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.4K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


